Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Blood Transfusion ; (12): 824-828, 2022.
Article in Chinese | WPRIM | ID: wpr-1004173

ABSTRACT

【Objective】 To provide references for clinical prediction of blood preparation and blood consumption, as well as the influencing factors of mass-transfusion by analyzing the perioperative blood transfusion in patients underwent heart transplantation. 【Methods】 The blood transfusions of 44 patients with heart transplantation completed in the Department of Cardiac Surgery of our hospital from March 2014 to January 2022 were retrospectively collected. Patient information included age, gender, preoperative diagnosis, relevant medical history, history of cardiac surgery, and history of antithrombotic medication. The risk factors of perioperative red blood cell transfusion in patients with heart transplantation were analyzed by univariate analysis method and multivariate logistic regression method. 【Results】 All 44(100%) heart transplant patients received blood components: the average transfusion units of red blood cells was 3.75(0, 7.5) U (72.73%), plasma 1 140 (597.5, 1782.5) mL (97.73%), cryoprecipitate 10(9.5±10) U(88.64%), platelets 1(1, 1.25) therapeutic amount (86.36%). The rate of massive transfusion of red blood cells was 45.45% (20/44). The univariate analysis found that there were significant differences in preoperative use of antithrombotic drugs, blood loss, and cardiopulmonary bypass time between the red blood cell transfusion group≤4 U (n=24) and the red blood cell transfusion group >4 U (n=20) (P<0.05). Multivariate Logistic regression analysis showed that preoperative antithrombotic drug treatment (n=15) was OR 5.900, 95%CI 1.313~26.521(P<0.05) and cardiopulmonary bypass time was OR 1.024, 95%CI 1.000~1.049(P<0.05). 【Conclusion】 The perioperative transfusion rate of blood components in cardiac transplant patients was high. The preoperative use of antithrombotic drugs, and prolonged cardiopulmonary bypass are risk factors for massive red blood cell transfusion.

2.
Chinese Journal of Nursing ; (12): 1157-1162, 2017.
Article in Chinese | WPRIM | ID: wpr-666468

ABSTRACT

Objective To evaluate the effectiveness of family management on improvement of management level for families with epilepsy children aged 0 to 6 years.Methods Families with epilepsy children aged 0 to 6 years hospitalized from April 1st to November 30th,2015 in our hospital were recruited and randomly divided into the control group and the intervention group.Within 24 hours after being diagnosed as epilepsy,general information questionnaire,epilepsy knowledge survey questionnaire and Family Management Scale(FaMM) were used for baseline survey.The control group received conventional treatment,nursing and health education.The intervention group received family management intervention for 6 months besides conventional treatment,nursing and health education.Epilepsy disease knowledge and family management were investigated at 3 months and 6 months after discharge.Results There was no difference between two groups at baseline (P>0.05).For different periods of the study,time factor and interaction existed in epilepsy disease knowledge and total score of FaMM(P<0.05).After intervention,there were significant differences in epilepsy disease knowledge and scores of FaMM between two groups(P<0.05).Conclusion Family management intervention can improve family management level of families with epilepsy children aged 0 to 6 years.The intervention contents are detailed and concrete,the intervention method is easy to perform,and the effects are significant,and the intervention is convenient for clinical application.

SELECTION OF CITATIONS
SEARCH DETAIL